The Quantellect read.As of Nov 19, 2026, 3 active firms cover AngioDynamics Inc: 3 rate it Buy or better, 0 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets are tightly clustered, $16.00 to $20.00, so the covering firms are broadly aligned. The average target of $18.00 sits 59% above the current $11.32. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees revenue growth near 7% this year and 5% next, consensus EPS building from about $-0.09 next quarter toward $-0.11 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 active firms
Buy
Strong Buy00%
Buy3100%
Neutral00%
Sell00%
Strong Sell00%
Based on 3 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$18.00
+58.9% upside
Average target across 3 active firms as of Nov 19, 2026 vs $11.33 current
Highest Target$20.00
Average Target$18.00
Lowest Target$16.00
Detailed analyst forecasts for ANGO
Showing 1–3 of 3 named analysts shown · 3 active firms in the rating projection
As of Nov 19, 2026, 3 of 3 active firms rate ANGO a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
ANGO EPS & revenue forecast
EPS · NEXT QUARTER
$-0.09
Range $-0.10 – $-0.07 · 3 analysts · -550% YoY
Next period, 3 analysts expect AngioDynamics Inc to earn $-0.09 a share (range $-0.10 – $-0.07), versus $0.02 a year earlier. Full-year consensus is $-0.28, growing to $-0.11 the year after.
REVENUE · NEXT QUARTER
$83.2M
Range $81.9M – $84.0M · 3 analysts · +4% YoY
Revenue is expected to reach $83.2M (range $81.9M – $84.0M), +4.0% year-over-year. Full-year consensus is $337.7M, rising to $354.9M next year.
Top analysts covering AngioDynamics Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ANGO.
#1
Yi Chen
HC Wainwright & Co. · Rank #350
Buy
$18.00+58.9% to target
Overall win rate
34%
+ Follow
#2
William Plovanic
Canaccord Genuity · Rank #370
Buy
$18.00+58.9% to target
Overall win rate
38%
+ Follow
#3
Frank Takkinen
Lake Street · Rank #514
Buy
$24.00+111.9% to target
Overall win rate
27%
+ Follow
#4
JY
John Young
Canaccord Genuity
Buy
$20.00+76.6% to target
Coverage
—
+ Follow
#5
IZ
Ilya Zubkov
Freedom Capital Markets
Buy
$16.00+41.3% to target
Coverage
—
+ Follow
ANGO stock forecast FAQ
What is ANGO's average 12-month price target?+
The 3 active firms with a live target average $18.00 for AngioDynamics Inc over the next 12 months, ranging from a $20.00 high to a $16.00 low, as of Nov 19, 2026.
Is ANGO stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 3 active firms as of Nov 19, 2026, 3 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for ANGO?+
The Street-high target is $20.00 (Canaccord Genuity), and the Street-low is $16.00 (Freedom Broker). The average of all 3 active-firm targets is $18.00.
How many active Wall Street firms cover ANGO?+
3 active firms have a recognized rating on AngioDynamics Inc as of Nov 19, 2026, and 3 active firms carry a live 12-month price target.
Who is the most accurate analyst covering ANGO?+
Among analysts who currently cover ANGO, Yi Chen of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #350). Their current call is Buy with a $18.00 target.
What is AngioDynamics Inc's projected EPS for next quarter?+
The consensus estimate is $-0.09 per share (range $-0.10 – $-0.07) across 3 analysts. Full-year EPS is projected at $-0.28, rising to $-0.11 the following year.
How much revenue is AngioDynamics Inc expected to report next quarter?+
Consensus revenue is $83.2M (range $81.9M – $84.0M). Full-year revenue is projected at $337.7M, growing to $354.9M next year.
Have analysts been upgrading or downgrading ANGO lately?+
As of Nov 19, 2026, 3 of 3 active firms rate ANGO a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ANGO calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.